All You Need to Know About Bio-Rad (BIO) Rating Upgrade to Buy

Investors might want to bet on Bio-Rad Laboratories (BIO) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change. For Bio-Rad, rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher. Harnessing the Power of ...